powered by centersite dot net
Medications
Resources
Basic InformationLatest News
Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?Antidepressant Efficacy Varies for Depressive Symptom ClustersDo You Need an Antibiotic?'Off-Label' Antidepressants Common, But Where's the Evidence?Docs More Likely to Prescribe Antibiotics If Patients Expect ThemSimilar Adverse Event Risk for Typical, Atypical AntipsychoticsRx Adherence Reminders No More Effective at 'Fresh Start' DatesThink You're Allergic to Penicillin? Check AgainExcessive FDA Regulation Driving High Drug PricesOutcomes-Based Pricing Suggested for New, Costly DrugsPrices Skyrocket on Drugs Widely Used by Seniors: Report1 in 6 U.S. Adults Takes a Psychiatric Drug: StudyU.S. Doctors Still Over-Prescribing Drugs: SurveyWider Low-Dose Aspirin Use Would Save U.S. $692 Billion: StudyHealth Tip: Get the Facts About AntibioticsThese Medicines Often Send Americans to ERsHealth Tip: Be Aware of Drug and Food InteractionsCan Time-Release Capsules Replace Daily Pills?Prices of Generic Heart Failure Drugs Vary WidelyAmericans Fed Up With Soaring Drug Prices: HealthDay/Harris PollSaturday, Oct. 22 Is Drug Take Back DayHow Older People Can Head Off Dangerous Drug InteractionsCDC: Too Many Antibiotics Still Being Prescribed in U.S.Codeine Not Safe for Kids, Pediatricians WarnHealth Tip: Reading the Label on OTC MedicationsMylan to Offer Generic EpiPenSteep Rise in U.S. Drug Prices Tied to Patent MonopoliesSpending on Compounded Drugs Skyrocketing
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Leading U.S. Doctors' Group Takes Aim at Rising Drug Prices

HealthDay News
by -- Robert Preidt
Updated: Jun 15th 2017

new article illustration

THURSDAY, June 15, 2017 (HealthDay News) -- The American Medical Association is calling for more transparency in drug pricing amid skyrocketing costs that are putting some lifesaving medications out of reach for patients and communities.

During its annual meeting, the doctors' group adopted new policies on drug pricing to protect patients.

"Taken together, these policies would bring much needed transparency to drug pricing and provide a clear benefit to consumers struggling with exorbitant costs," AMA President-Elect Dr. Barbara McAneny said in an association news release.

One policy calls on pharmaceutical companies to list the suggested retail prices of drugs in direct-to-consumer ads. The AMA will urge federal regulators to include that requirement.

The association pointed out that one study found a 34 percent increase in prices for prescription drugs advertised directly to consumers. For other medications, the increase was 5 percent.

Direct-to-consumer ads were illegal in the United States until 1997. Only one other country -- New Zealand -- currently allows these ads.

Another policy is meant to tackle the sudden increase in the cost of naloxone. This is a lifesaving drug used to reverse the effects of opioid overdose. Community groups, schools, first responders and local governments rely on naloxone to save lives, but are finding it increasingly expensive.

The AMA plans to raise awareness about the "troubling conduct" of the three makers of naloxone. The companies sought the help of physicians, community groups and elected officials to raise awareness and insurance coverage of naloxone and then suddenly and significantly boosted the cost of the drug after public policy changes increased access to naloxone, according to the association.

"There seems to be no logic -- or warning -- to these price spikes. In the case of naloxone, communities are struggling to afford a lifesaving treatment. Sunlight is needed to help respond to price shifts, because if the pricing trends continue, patients and communities will not be able to afford lifesaving drugs," McAneny said.

The AMA also said it will support legislative, regulatory and advocacy efforts to improve access to affordable naloxone.

A third new policy calls on drug companies to give public notice before increasing the price of certain drugs by more than 10 percent during a 12-month period. This would provide information about the most serious cases of price gouging, particularly for older drugs, according to the AMA.

More information

For more on drug pricing, visit the U.S. Centers for Medicare and Medicaid Services.